Looking ahead with vericiguat for the broader HFrEF population

11 May 2024 (12:58 - 13:06)

Organised by:

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

5 More presentations in this session

Presentation thumbnail

Embracing change on worsening heart failure management

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Taking action to optimize therapy after a worsening heart failure event

Professor J. Bauersachs (Hannover, DE)

Presentation thumbnail

Overcoming the protection gap in the real world

Professor M. Senni (Bergamo, IT)

Presentation thumbnail

Expert panel discussion and Q&A

Professor J. Bauersachs (Hannover, DE) Professor C. Lam (Singapore, SG) Professor M. Senni (Bergamo, IT) Professor J. Butler (Dallas, US)

Presentation thumbnail

Key takeaways and close

Professor J. Butler (Dallas, US)

Access the full session

Session thumbnail

Expanding horizons: HFrEF management across the spectrum of risk

The Event

Event poster

Heart Failure 2024

11 May 2024 12:58 CET

You may be interested in

Congress Session

Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

18 May 2025

Congress Presentation

Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects

28 August 2020

Congress Presentation

Challenging perceptions: why add more to your HFrEF medication toolkit? - discussion and Q&A

30 August 2026

Congress Session

What’s on the horizon in heart failure: precision medicine and tailored treatment

18 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources